Digitalis

Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose, Fourth Edition

Volumn , Issue , 2007, Pages 949-962

  Lapostolle, Frédéric ^a   Borron, Stephen W ^b,c,d  

^a UNIVERSITÉ PARIS 13   (France)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Forensic Sciences Building   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84886337847     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0693-4.50063-3     Document Type: Chapter

References (50)

1. A Schwartz (1976) Is the cell membrane Na+, K+-ATPase enzyme system the pharmacological receptor for digitalis? Circ Res 39(1), 1-7.
2. ME Silverman (1989) William Withering and an account of the foxglove. Clin Cardiol 12(7), 415-418.
3. GJ Ordog, S Benaron, V Bhasin, et al. (1987) Serum digoxin levels and mortality in 5,100 patients. Ann Emerg Med 16(1), 32-39.
4. TW Smith, E Haber, L Yeatman and VP Butler Jr (1976) Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med 294(15), 797-800.
5. GA Beller, TW Smith, WH Abelmann, E Haber and WB Hood Jr (1971) Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med 284(18), 989-997.
6. SW Borron, C Bismuth and J Muszynski (1997) Advances in the management of digoxin toxicity in the older patient. Drugs Aging 10(1), 18-33.
7. P Taboulet, FJ Baud, C Bismuth and E Vicaut (1993) Acute digitalis intoxication—is pacing still appropriate? J Toxicol Clin Toxicol 31(2), 261-273.
8. C Bismuth, G Motte, F Conso, M Chauvin and M Gaultier (1977) Acute digoxin intoxication treated by intracardiac pacemaker: experience in sixty-eight patients. Clin Toxicol 10 443-456.
9. NR Slifman, WR Obermeyer, BK Aloi, et al. (1998) Contamination of botanical dietary supplements by Digitalis lanata. N Engl J Med 339(12), 806-811.
10. JE Doherty (1973) Digitalis glycosides. Pharmacokinetics and their clinical implications. Ann Intern Med 79(2), 229-238.
11. JE Doherty, N de Soyza, JJ Kane, et al. (1978) Clinical pharmacokinetics of digitalis glycosides. Prog Cardiovasc Dis 21(2), 141-158.
12. J Lindenbaum, DG Rund, VP Butler Jr, et al. (1981) Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 305(14), 789-794.
13. TW Smith (1988) Digitalis. Mechanisms of action and clinical use. N Engl J Med 318(6), 358-365.
14. SB Arnold, RC Byrd, W Meister, et al. (1980) Long-term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 303(25), 1443-1448.
15. CD Mulrow, JR Feussner and R Velez (1984) Reevaluation of digitalis efficacy. New light on an old leaf. Ann Intern Med 101(1), 113-117.
16. H Krum, JT Bigger Jr, RL Goldsmith and M Packer (1995) Effect of long-term digoxin therapy on autonomic function in patients with chronic heart failure. J Am Coll Cardiol 25(2), 289-294.
17. Digitalis Investigation Group (1997) The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 336(8), 525-533.
18. E Braunwald (1985) Effects of digitalis on the normal and the failing heart. J Am Coll Cardiol 5(5 Suppl A), 51A-59A.
19. MR Rosen (1985) Cellular electrophysiology of digitalis toxicity. J Am Coll Cardiol 5(5 Suppl A), 22A-34A.
20. JT Bigger Jr (1979) The quinidine-digoxin interaction: what do we know about it? N Engl J Med 301(14), 779-781.
21. FI Marcus (1985) Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol 5(5 Suppl A), 82A-90A.
22. PR Pentel and DM Salerno (1990) Cardiac drug toxicity: digitalis glycosides and calcium-channel and beta-blocking agents. Med J Aust 152(2), 88-94.
23. EB Leahey Jr, JA Reiffel, EG Giardina and JT Bigger Jr (1980) The effect of quinidine and other oral antiarrhythmic drugs on serum digoxin. A prospective study. Ann Intern Med 92(5), 605-608.
24. K Nademanee, R Kannan, J Hendrickson, et al. (1984) Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol 4(1), 111-116.
25. HO Klein, R Lang, E Di Segni and E Kaplinsky (1980) Verapamil-digoxin interaction. N Engl J Med 303(3), 160.
26. I Robieux, P Dorian, J Klein, et al. (1992) The effects of cardiac transplantation and cyclosporine therapy on digoxin pharmacokinetics. J Clin Pharmacol 32(4), 338-343.
27. Y Iesaka, K Aonuma, AJ Gosselin, et al. (1983) Susceptibility of infarcted canine hearts to digitalis-toxic ventricular tachycardia. J Am Coll Cardiol 2(1), 45-51.
28. JE Muller, ZG Turi, PH Stone, et al. (1986) Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med 314(5), 265-271.
29. FE Marchlinski, BG Hook and DJ Callans (1991) Which cardiac disturbances should be treated with digoxin immune Fab (ovine) antibody? Am J Emerg Med 9(2 Suppl 1), 24-34.
30. D Da Costa, WJ Brady and J Edhouse (2002) Bradycardias and atrioventricular conduction block. BMJ 324(7336), 535-538.
31. H Mahdyoon, G Battilana, H Rosman, et al. (1990) The evolving pattern of digoxin intoxication: observations at a large urban hospital from 1980 to 1988. Am Heart J 120(5), 1189-1194.
32. G Brunner, R Zweiker and GJ Krejs (2000) A toxicological surprise. Lancet 356(9239), 1406.
33. M Gaultier, JJ Welti, C Bismuth, et al. (1976) [Severe digitalis intoxication. Prognostic factors. Value and limitations of electrosystolic pacemaking (apropos of 133 cases).] Ann Med Interne (Paris) 127(10), 761-766.
34. C Pap, G Zacher and M Karteszi (2005) [Prognosis in acute digitalis poisoning.]. Orv Hetil 146(11), 507-513.
35. EM Antman, TL Wenger, VP Butler Jr, et al. (1990) Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study. Circulation 81(6), 1744-1752.
36. AR Hickey, TL Wenger, VP Carpenter, et al. (1991) Digoxin Immune Fab therapy in the management of digitalis intoxication: safety and efficacy results of an observational surveillance study. J Am Coll Cardiol 17(3), 590-598.
37. SW Graves, B Brown and R Valdes Jr (1983) An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 99(5), 604-608.
38. TW Smith (1985) Pharmacokinetics, bioavailability and serum levels of cardiac glycosides. J Am Coll Cardiol 5(5 Suppl A), 43A-50A.
39. RM Gowda, RA Cohen and IA Khan (2003) Toad venom poisoning: resemblance to digoxin toxicity and therapeutic implications. Heart 89(4), e14.
40. T Kwan, AD Paiusco and L Kohl (1992) Digitalis toxicity caused by toad venom. Chest 102(3), 949-950.
41. LS Newman, MW Feinberg and HE LeWine (2004) Clinical problem-solving. A bitter tale. N Engl J Med 351(6), 594-599.
42. FS Wamboldt, JW Jefferson and MZ Wamboldt (1986) Digitalis intoxication misdiagnosed as depression by primary care physicians. Am J Psychiatry 143(2), 219-221.
43. PA Chyka, D Seger, EP Krenzelok and JA Vale (2005) Position paper: Single-dose activated charcoal. Clin Toxicol (Phila) 43(2), 61-87.
44. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists (1999) Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 37(6), 731-751.
45. JB Hack, JH Woody, DE Lewis, et al. (2004) The effect of calcium chloride in treating hyperkalemia due to acute digoxin toxicity in a porcine model. J Toxicol Clin Toxicol 42(4), 337-342.
46. JY Chen, PY Liu, JH Chen, et al. (2004) Safety of transvenous temporary cardiac pacing in patients with accidental digoxin overdose and symptomatic bradycardia. Cardiology 102(3), 152-155.
47. EJ Reisdorff, MR Clark and BL Walters (1986) Acute digitalis poisoning: the role of intravenous magnesium sulfate. J Emerg Med 4(6), 463-469.
48. P Taboulet, FJ Baud and C Bismuth (1993) Clinical features and management of digitalis poisoning—rationale for immunotherapy. J Toxicol Clin Toxicol 31(2), 247-260.
49. A Smolarz, E Roesch, E Lenz, et al. (1985) Digoxin specific antibody (Fab) fragments in 34 cases of severe digitalis intoxication. J Toxicol Clin Toxicol 23(4–6), 327-340.
50. AD Woolf, T Wenger, TW Smith and FH Lovejoy Jr (1992) The use of digoxin-specific Fab fragments for severe digitalis intoxication in children. N Engl J Med 326(26), 1739-1744.